首頁 > 市場調查報告書 > 工業機械

工作機械

市場調查報告書

商品編碼

1890975

注射型流感疫苗市場按疫苗類型、價數、給藥途徑、年齡層、技術平台、通路、適應症、株類型和地區分類

Injection Flu Shot Market, By Vaccine Type, By Valency, By Route of Administration, By Age Group, By Technology Platform, By Distribution Channel, By Indication, By Strain Type, By Geography

出版日期: 2025年11月10日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，注射型流感疫苗市場規模將達到 91.2 億美元，到 2032 年將達到 150.3 億美元，2025 年至 2032 年的複合年成長率為 7.4%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	91.2億美元
歷史數據時期：	2020-2024	預測期：	2025-2032
預測期間（2025-2032年）：	7.40%	2032 年的預測值：	150.3億美元

全球注射型流感疫苗市場是全球免疫領域的重要組成部分，涵蓋了透過肌肉注射給藥的流感疫苗的研發、生產和分銷。這些疫苗是預防季節性流感的主要手段，季節性流感每年影響全球數百萬人，造成重大的公共衛生和經濟負擔。注射型流感疫苗市場包含多種疫苗配方，旨在提供多種流感病毒株的保護，其中包括三價和四價去活化流感疫苗、減毒活病毒疫苗和重組流感疫苗。

市場動態受多種因素影響，例如季節性需求模式、政府疫苗接種政策、醫療基礎設施建設以及不斷發展的疫苗技術。大型製藥和生技公司持續增加研發投入，以提高疫苗效力、減少副作用並改善生產流程。市場涵蓋多種分銷管道，包括醫院、診所、藥房和大型疫苗接種中心，並服務從兒童到老年人的各個年齡層。在全球注射型流感疫苗市場持續發展的推動下，技術進步以及已開發市場和新興市場疫苗接種管道的不斷擴大，加之人們對預防性醫療保健和疫苗接種計劃經濟效益的認知不斷提高，推動了全球注射型流感疫苗市場的發展。

市場動態

全球注射型流感疫苗市場正加速成長，這主要得益於幾個關鍵促進因素。政府加強對疫苗接種計畫的投入和支持力度，尤其是在應對流感大流行和季節性流感疫情方面，是推動市場成長的主要因素。消費者健康意識的提高，以及老年人口的成長（老年人口更容易出現流感併發症），顯著推動了市場需求。疫苗研發的進步，包括細胞培養和重組疫苗等生產技術的進步，提高了疫苗的有效性和安全性，從而提高了患者的接受度。新興經濟體醫療基礎設施的擴建和低溫運輸物流的改善，也促進了疫苗的分發和供應。

然而，該市場也面臨著許多顯著的限制因素，包括部分人口對疫苗的猶豫態度、對副作用的擔憂以及可能延緩產品核可和上市的複雜監管流程。季節性需求波動給製造商的供應鏈和庫存管理帶來挑戰。高昂的研發成本，尤其是在開發通用流感疫苗方面，對市場相關人員造成了財務壓力。此外，來自其他接種管道（例如鼻噴疫苗）的競爭可能會限制注射產品的市場佔有率。儘管存在這些挑戰，但開發中國家擁有大量未接種疫苗的人口）、可能提供長期保護的通用流感疫苗的研發以及數位健康技術在改善疫苗接種追蹤和患者參與度方面的應用，都蘊藏著巨大的機遇。

本次調查的主要特點

本報告對全球注射型流感疫苗市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率（%）。
它還重點介紹了各個細分市場的潛在商機，並解釋了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與企業。
該研究根據以下參數對全球注射型流感疫苗市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
這份全球注射型流感疫苗市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過全球注射型流感疫苗市場分析中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第13章競爭格局

Sanofi Pasteur
GlaxoSmithKline
CSL Seqirus
AstraZeneca
Pfizer
Merck
Moderna
Novavax
Bharat BIoTech
Sinovac BIoTech
Serum Institute of India
Daiichi Sankyo
Emergent BioSolutions
BIKEN Co., Ltd.
Abbott Laboratories

第14章分析師建議

機會
一致的機會地圖

第15章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI8878

Injection Flu Shot Market is estimated to be valued at USD 9.12 Bn in 2025 and is expected to reach USD 15.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 9.12 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	USD 15.03 Bn

The global injection flu shot market represents a critical segment within the global immunization landscape, encompassing the development, manufacturing, and distribution of influenza vaccines administered through intramuscular injection. These vaccines serve as the primary prophylactic measure against seasonal influenza, which affects millions of individuals worldwide annually and poses significant public health and economic burdens. The injection flu shot market includes various vaccine formulations such as trivalent and quadrivalent inactivated influenza vaccines, live attenuated influenza vaccines, and recombinant influenza vaccines, each designed to provide protection against multiple influenza virus strains.

The market dynamics are influenced by factors including seasonal demand patterns, government immunization policies, healthcare infrastructure development, and evolving vaccine technologies. Major pharmaceutical companies and biotechnology firms continuously invest in research and development to enhance vaccine efficacy, reduce adverse effects, and improve manufacturing processes. The market encompasses diverse distribution channels including hospitals, clinics, pharmacies, and mass vaccination centers, serving various demographic segments from pediatric to geriatric populations. With increasing awareness about preventive healthcare and the economic benefits of vaccination programs, the global injection flu shot market continues to evolve, driven by technological advancements and expanding accessibility across both developed and emerging markets.

Market Dynamics

The global injection flu shot market is propelled by several key drivers that collectively fuel its growth trajectory. Increasing government initiatives and funding for vaccination programs, particularly in response to pandemic preparedness and seasonal flu outbreaks, serve as primary growth catalysts. Rising healthcare awareness among consumers, coupled with growing elderly populations who are more susceptible to influenza complications, significantly drives market demand. Technological advancements in vaccine development, including cell-based and recombinant vaccine production methods, enhance vaccine efficacy and safety profiles, attracting broader patient acceptance. Expanding healthcare infrastructure in emerging economies and improved cold chain logistics facilitate better vaccine distribution and accessibility.

However, the market faces notable restraints including vaccine hesitancy among certain population segments, concerns about adverse effects, and regulatory complexities that can delay product approvals and market entry. Seasonal demand fluctuations create supply chain challenges and inventory management issues for manufacturers. High research and development costs, particularly for developing universal flu vaccines, pose financial constraints for market players. Additionally, competition from alternative vaccination routes such as nasal spray vaccines may limit market share for injection-based products. Despite these challenges, significant opportunities emerge from untapped markets in developing countries with large unvaccinated populations, development of universal flu vaccines that could provide long-term protection, and integration of digital health technologies for improved vaccination tracking and patient engagement.

Key Features of the Study

This report provides in-depth analysis of the global injection flu shot market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global injection flu shot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline, CSL Seqirus, AstraZeneca, Pfizer, Merck, Moderna, Novavax, Bharat Biotech, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, Emergent BioSolutions, BIKEN Co., Ltd., and Abbott Laboratories.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global injection flu shot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injection flu shot market

Market Segmentation

Vaccine Type Insights (Revenue, USD Bn, 2020 - 2032)
- Inactivated
- Live Attenuated
Valency Insights (Revenue, USD Bn, 2020 - 2032)
- Quadrivalent
- Trivalent
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Injection
- Nasal Spray
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
Technology Platform Insights (Revenue, USD Bn, 2020 - 2032)
- Egg-based
- Cell-based
- Recombinant
- mRNA-based
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital and Retail Pharmacies
- Government & Institutional Suppliers
- Others (e.g., NGOs, International Organizations)
Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Seasonal
- Pandemic
Strain Type Insights (Revenue, USD Bn, 2020 - 2032)
- A(H1N1)
- A(H3N2)
- B (Yamagata)
- B (Victoria)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Sanofi Pasteur
- GlaxoSmithKline
- CSL Seqirus
- AstraZeneca
- Pfizer
- Merck
- Moderna
- Novavax
- Bharat Biotech
- Sinovac Biotech
- Serum Institute of India
- Daiichi Sankyo
- Emergent BioSolutions
- BIKEN Co., Ltd.
- Abbott Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Injection Flu Shot Market, By Vaccine Type
- Global Injection Flu Shot Market, By Valency
- Global Injection Flu Shot Market, By Route of Administration
- Global Injection Flu Shot Market, By Age Group
- Global Injection Flu Shot Market, By Technology Platform
- Global Injection Flu Shot Market, By Distribution Channel
- Global Injection Flu Shot Market, By Indication
- Global Injection Flu Shot Market, By Strain Type
- Global Injection Flu Shot Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Injection Flu Shot Market, By Vaccine Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Inactivated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Live Attenuated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Injection Flu Shot Market, By Valency, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Quadrivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Trivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Injection Flu Shot Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nasal Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Injection Flu Shot Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Injection Flu Shot Market, By Technology Platform, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Egg-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cell-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
mRNA-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Injection Flu Shot Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital and Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government & Institutional Suppliers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (e.g., NGOs, International Organizations)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Injection Flu Shot Market, By Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Seasonal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pandemic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Injection Flu Shot Market, By Strain Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
A(H1N1)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
A(H3N2)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
B (Yamagata)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
B (Victoria)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Injection Flu Shot Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

13. Competitive Landscape

Sanofi Pasteur
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Seqirus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Moderna
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novavax
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sinovac Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Serum Institute of India
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Daiichi Sankyo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BIKEN Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies